These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 617787)

  • 41. Christmas factor concentrates. The clinical use of several preparations.
    Tullis JL; Breen FA
    Bibl Haematol; 1970; 34():40-51. PubMed ID: 5436352
    [No Abstract]   [Full Text] [Related]  

  • 42. Tests of hemostasis in swine: normal values and values in pigs affected with von Willebrand's disease.
    Bowie EJ; Owen CA; Zollman PE; Thompson JH; Fass DN
    Am J Vet Res; 1973 Nov; 34(11):1405-7. PubMed ID: 4542959
    [No Abstract]   [Full Text] [Related]  

  • 43. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates.
    Dusel CH; Grundmann C; Eich S; Seitz R; König H
    Blood Coagul Fibrinolysis; 2004 Jul; 15(5):405-11. PubMed ID: 15205589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Hageman factor, plasma thromboplastin antecedent, thrombin and other clotting factors by phenylglyoxal hydrate (38500).
    Radnoff OD; Saito H
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):177-82. PubMed ID: 236567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on the thrombogenic activities in two prothrombin complex concentrates.
    Hedner U; Nilsson IM; Bergentz SE
    Thromb Haemost; 1979 Oct; 42(3):1022-32. PubMed ID: 315624
    [No Abstract]   [Full Text] [Related]  

  • 46. The preparation of the factors IX, II, and X concentrate by means of DEAE cellulos and its therapeutic effectiveness.
    Uszyński L; Poszwiński P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):591-4. PubMed ID: 54310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood clotting defect in hibernating ground squirrels (Citellus tridecemlineatus).
    Lechler E; Penick GD
    Am J Physiol; 1963 Nov; 205(5):985-8. PubMed ID: 5877429
    [No Abstract]   [Full Text] [Related]  

  • 48. The mechanism of blood coagulation.
    Owren PA; Stormorken H
    Ergeb Physiol; 1973; 68():1-53. PubMed ID: 4593726
    [No Abstract]   [Full Text] [Related]  

  • 49. Characteristics and thrombogenicity of prothrombin complex concentrates.
    Sakuragawa N; Takahashi K; Hoshiyama M; Niiya K; Itoh M; Matsuoka M; Ohnishi Y
    Thromb Res; 1977 Feb; 10(2):315-8. PubMed ID: 850913
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical use of human prothrombin complexes.
    Tullis JL; Melin M; Jurigian P
    N Engl J Med; 1965 Sep; 273(13):667-74. PubMed ID: 5827030
    [No Abstract]   [Full Text] [Related]  

  • 51. Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates.
    Kim HC; McMillan CW; White GC; Bergman GE; Horton MW; Saidi P
    Blood; 1992 Feb; 79(3):568-75. PubMed ID: 1531035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
    Tullis JL; Melin M
    Bibl Haematol; 1968; 29():1134-9. PubMed ID: 5700309
    [No Abstract]   [Full Text] [Related]  

  • 53. Thrombin activates factor XI on activated platelets in the absence of factor XII.
    Oliver JA; Monroe DM; Roberts HR; Hoffman M
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):170-7. PubMed ID: 9888880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Commercial preparations of prothrombin complex. A clinical comparison.
    Gunay U; Choi HS; Maurer HS; Hruby M; Honig GR
    Am J Dis Child; 1973 Dec; 126(6):775-7. PubMed ID: 4759364
    [No Abstract]   [Full Text] [Related]  

  • 55. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 56. FACTOR XI (P.T.A.) DEFICIENCY WITH NO HEMORRHAGIC SYMPTOMS; CASE REPORT.
    TODD M; WRIGHT IS
    Thromb Diath Haemorrh; 1964 Apr; 11():186-94. PubMed ID: 14167101
    [No Abstract]   [Full Text] [Related]  

  • 57. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
    Chang P; Aronson DL; Borenstein DG; Kessler CM
    Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
    DOKU HC; TAYLOR RG; SISE HS; BECKER R
    J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources.
    Lefkowitz JB; Monroe DM; Kasper CK; Roberts HR
    Am J Hematol; 1993 Jul; 43(3):177-82. PubMed ID: 8352232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparinised clotting factor concentrates in patients with Christmas disease and liver disease.
    Preston FE; Malia RG; Lilleyman JS; Blackburn EK
    Thromb Haemost; 1977 Aug; 38(2):504-9. PubMed ID: 579492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.